Vendor Neutral Archive & PACS Market: By Product Type, By Application, By End User, and Region Forecast 2020-2031

Vendor Neutral Archive (VNA) & PACS Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product Type (Department, Multi-department, Multi-site), By Application (Cardiology, Oncology, Neurology, Others), By End User (Hospital, ASC< Diagnostic Centers), and Region Forecast 2020-2031

Report ID: 16770 | Published Date: Apr 2023 | No. of Pages: 197 | Format: Report available in PDF format Report available in Excel Format

Vendor Neutral Archive (VNA) & PACS Market size was valued at US$ 3,600 million in 2024 and is expected to reach US$ 5,800 million by 2031, growing at a significant CAGR of 6.9% from 2025-2031. Moreover, the U.S. Vendor Neutral Archive (VNA) & PACS Market is projected to grow significantly, reaching an estimated value of US$ 2,200 million by 2031. Vendor Neutral Archive (VNA) and Picture Archiving and Communication Systems (PACS) are transforming the way medical imaging data is stored, retrieved, and shared across healthcare systems. These technologies support clinical efficiency, enable interoperability, and enhance diagnostic precision.

The rising need for centralized imaging systems, combined with the growing complexity of clinical workflows, is fueling adoption. With healthcare providers seeking scalable, long-term archiving solutions, VNA and PACS are becoming integral to digital health infrastructure. The ability to consolidate multi-department imaging into a unified archive is now a core priority for hospitals and diagnostic centers seeking operational excellence and regulatory compliance. The market continues to evolve in response to the increasing demand for integrated healthcare IT platforms. A shift from traditional siloed systems to interoperable, cloud-enabled platforms is gaining momentum.

Moreover, the rise in diagnostic imaging procedures, growing healthcare data volumes, and emphasis on timely and coordinated care further underscore the need for advanced archiving and communication solutions. Market players are focusing on modular, flexible deployment models that serve multi-site and multi-department requirements. These trends, supported by strong investments in digital health infrastructure, position the VNA & PACS ecosystem at the forefront of medical IT advancement.

Facts & Figures

  • Multi-site deployment models are gaining preference due to expanding hospital networks and consolidation of healthcare systems.
  • AI-powered PACS platforms are entering mainstream clinical practice with early adoption in oncology and cardiology imaging.
  • Cloud-based VNA models are experiencing a strong uptake, especially among outpatient and diagnostic imaging centers.
  • Interoperability and HL7/DICOM compliance are now baseline requirements in most procurement decisions for new PACS systems.

Key Developments:

  • In March 2024, Philips Healthcare expanded its enterprise imaging solution portfolio with a cloud-enabled VNA platform targeting European hospital networks.
  • In February 2024, Sectra AB secured a 10-year PACS contract with a major academic health center in Canada to support radiology and pathology imaging consolidation.
  • In January 2024, Fujifilm announced the integration of AI-assisted diagnostic features into its PACS platform to improve radiology workflow efficiency.

Vendor Neutral Archive (VNA) & PACS Market Segmentation:

Based on the product type:

  • Department
  • Multi-department
  • Multi-site

Among product types, the multi-site VNA systems are gaining notable traction due to their capacity to support healthcare networks spread across multiple geographical locations. These systems enable centralized data management, facilitate image sharing between facilities, and reduce redundant imaging. With hospital chains expanding and collaborative care models on the rise, the ability to access imaging data across branches is becoming a critical operational advantage. Multi-site VNA platforms ensure standardized storage protocols and compliance across locations, making them particularly suitable for integrated delivery networks. This capability not only boosts diagnostic consistency but also enhances patient experiences through coordinated and faster care delivery.

Based on the modality:

  • CT
  • MRI
  • X-ray
  • Ultrasound
  • Mammo
  • PET

In terms of modality, CT imaging contributes significantly to the growth of PACS implementation. The high diagnostic value of CT scans in a wide range of clinical applications makes them essential in modern diagnostic settings. Given the massive volume of images generated by multi-slice CT scanners, healthcare institutions rely heavily on PACS systems for efficient image storage and retrieval. Moreover, the widespread use of CT imaging in emergency care, oncology, and cardiovascular diagnostics underscores the necessity for seamless archiving and access. PACS platforms tailored for CT modalities optimize image resolution, support advanced 3D visualization, and ensure real-time sharing among specialists.

Based on the application:

  • Cardiology
  • Oncology
  • Neurology
  • Others

Cardiology represents one of the leading application areas within the VNA & PACS landscape due to the image-intensive nature of cardiovascular diagnostics. From echocardiograms to CT angiograms, cardiology departments require rapid access to large volumes of imaging data. The integration of PACS allows cardiologists to review, compare, and report findings efficiently. Furthermore, VNA supports long-term archiving of cardiac imaging studies, which are often needed for tracking chronic conditions or evaluating treatment efficacy. As cardiovascular disease remains a leading global health burden, the demand for robust imaging infrastructure tailored to cardiology continues to propel market interest and investment.

Based on the End user:

  • Hospital
  • ASC
  • Diagnostic centre

Hospitals are the most dominant end-users in the VNA and PACS market owing to their comprehensive diagnostic needs and high patient throughput. Large tertiary hospitals and academic medical centres often operate multiple imaging modalities, which require integrated archiving systems for operational efficiency. PACS systems streamline diagnostic workflows by ensuring real-time image availability, while VNA platforms support enterprise-level archiving and compliance. Additionally, hospitals often serve as training and research hubs, further necessitating robust imaging repositories. As hospitals expand their digital health ecosystems, VNA and PACS integration becomes a foundational element in delivering high-quality, coordinated care across departments and specialties.

Global Vendor Neutral Archive Picture Archiving And Communication Systems Market Summary

Study Period

2025-2031

Base Year

2024

CAGR

6.9%

Largest Market

North-America

Fastest Growing Market

Asia-Pacific

Vendor Neutral Archive (VNA) & PACS Market Dynamics

Drivers

The primary growth driver of the Vendor Neutral Archive (VNA) and PACS market is the growing demand for interoperability and seamless data exchange in healthcare systems. With the proliferation of imaging modalities across departments and sites, providers require centralized solutions to manage and retrieve diagnostic images efficiently. VNA and PACS offer integrated storage frameworks that allow image access independent of hardware vendors. This interoperability not only reduces long-term costs but also boosts clinical decision-making. In parallel, the surge in telemedicine and remote diagnostics post-COVID has added pressure to streamline image access and sharing. Additionally, government mandates and incentives for electronic health records (EHR) are further pushing the adoption of standardized, vendor-neutral systems.

Restraints

A significant restraint in the VNA and PACS market lies in the high implementation and integration costs associated with these systems. For many small to mid-sized healthcare facilities, the capital expenditure required to transition from legacy storage systems to fully integrated PACS and VNA platforms remains prohibitive. Additionally, interoperability, while a key value proposition, often presents technical challenges when integrating with multiple existing hospital information systems. The lack of skilled personnel to manage, maintain, and optimize these complex platforms also affects adoption rates. Moreover, data migration from older systems to new VNA platforms can be time-consuming, technically intensive, and risky in terms of data loss or corruption.

Opportunities

An emerging opportunity in the VNA and PACS market lies in the expansion of cloud-based solutions tailored for scalable and remote deployment. Healthcare organizations are increasingly seeking flexible and cost-efficient storage models that reduce dependence on on-site hardware. Cloud-native VNA platforms provide elasticity in storage and enable secure, anytime access to imaging data for clinicians across networks and geographies. This is particularly appealing for multi-site healthcare systems and growing hospital networks. Furthermore, artificial intelligence (AI) integration with PACS is gaining momentum. AI-enabled PACS not only accelerates image analysis and diagnostic workflows but also improves reporting accuracy, offering substantial potential for clinical efficiency and innovation.

Trends

One of the most defining trends shaping the VNA and PACS market is the integration of artificial intelligence (AI) to optimize diagnostic imaging workflows. AI-driven tools are being embedded within PACS to automate image recognition, enhance visualization, and assist in anomaly detection, particularly in radiology and oncology. These intelligent systems support faster turnaround times and more accurate reporting by flagging critical findings. As diagnostic demands continue to rise, AI-backed PACS is addressing radiologist burnout and improving overall productivity. Additionally, the trend reflects a strategic convergence of data management and intelligent analytics—helping healthcare providers derive actionable insights from stored imaging data, beyond archiving purposes.

Global Vendor Neutral Archive Picture Archiving And Communication Systems Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2025-2031

Market Size in 2024

US$ 3,600 million

Market Size in 2031

US$ 5,800 million

Market CAGR

6.9%

By Product Type

  • Department
  • Multi-department
  • Multi-site

By Modality

  • CT
  • MRI
  • X-ray
  • Ultrasound
  • Mammo
  • PET

By Application

  • Cardiology
  • Oncology
  • Neurology
  • Others

By End User

  • Hospital
  • ASC
  • Diagnostic centre

By Region

  • North America (U.S., Canada)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
  • Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
  • Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

Analyst Review

According to PBI Analyst, the market is undergoing a paradigm shift, driven by rising demand for interoperable, scalable, and intelligent imaging solutions. As healthcare becomes increasingly data-centric, these technologies are enabling facilities to consolidate, access, and analyze diagnostic imaging more efficiently. Notably, the transition toward cloud-based deployments and AI-enhanced workflows marks a significant evolution in the space. Leading hospitals are leveraging these systems to enhance patient care coordination, reduce imaging redundancy, and improve clinical decision-making. The market remains dynamic, with new entrants innovating cost-effective and compliant platforms tailored for mid-sized and multi-site providers, making the technology accessible across the care continuum.

Key Features of the Report

  • The vendor neutral archive (VNA) & PACS market report provides granular level information about the market size, regional market share, historic market (2020-2024), and forecast (2025-2031)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis

Download Free Sample Report

Frequently Asked Questions

The vendor neutral archive (VNA) & PACS market size was valued at US$ 3,600 million in 2024 and is projected to grow at a CAGR of 6.9% from 2025-2031

The key driver is the growing demand for interoperability and centralized image archiving across multi-site and multi-department healthcare facilities.

The integration of artificial intelligence in PACS platforms is the most prominent trend, enabling automated diagnostics and improved clinical workflows.

Market research is segmented based on type, modality, application, and end-user.

Asia-Pacific is the emerging region due to rising diagnostic volumes, digital health initiatives, and increasing investments in healthcare IT.

Content Updated Date: Aug 2025

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Vendor Neutral Archive (VNA) & PACS Market Introduction 
2.1.Global Vendor Neutral Archive (VNA) & PACS Market  - Taxonomy
2.2.Global Vendor Neutral Archive (VNA) & PACS Market  - Definitions
2.2.1.Product Type
2.2.2.Modality
2.2.3.Application
2.2.4.End User
2.2.5.Region
3.Global Vendor Neutral Archive (VNA) & PACS Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Vendor Neutral Archive (VNA) & PACS Market Analysis, 2020 - 2024 and Forecast 2025 - 2031
4.1.  Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Vendor Neutral Archive (VNA) & PACS Market  By Product Type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
5.1. Department
5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Multi-department
5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Multi-site
5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6.Global Vendor Neutral Archive (VNA) & PACS Market  By Modality, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
6.1. CT
6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. MRI
6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. X-ray
6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Ultrasound
6.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Mammo
6.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
6.6. PET
6.6.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.6.3. Market Opportunity Analysis 
7.Global Vendor Neutral Archive (VNA) & PACS Market  By Application, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
7.1. Cardiology
7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Oncology
7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Neurology
7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Others
7.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
8.Global Vendor Neutral Archive (VNA) & PACS Market  By End User, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
8.1. Hospital
8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. ASC
8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Diagnostic centre
8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
9.Global Vendor Neutral Archive (VNA) & PACS Market  By Region, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10.North America Vendor Neutral Archive (VNA) & PACS Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
10.1. Product Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Department
10.1.2.Multi-department
10.1.3.Multi-site
10.2.  Modality Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.CT
10.2.2.MRI
10.2.3.X-ray
10.2.4.Ultrasound
10.2.5.Mammo
10.2.6.PET
10.3.  Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Cardiology
10.3.2.Oncology
10.3.3.Neurology
10.3.4.Others
10.4.  End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Hospital
10.4.2.ASC
10.4.3.Diagnostic centre
10.5.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11.Europe Vendor Neutral Archive (VNA) & PACS Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
11.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Department
11.1.2.Multi-department
11.1.3.Multi-site
11.2.  Modality Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.CT
11.2.2.MRI
11.2.3.X-ray
11.2.4.Ultrasound
11.2.5.Mammo
11.2.6.PET
11.3.  Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Cardiology
11.3.2.Oncology
11.3.3.Neurology
11.3.4.Others
11.4.  End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Hospital
11.4.2.ASC
11.4.3.Diagnostic centre
11.5.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
12.Asia Pacific (APAC) Vendor Neutral Archive (VNA) & PACS Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
12.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Department
12.1.2.Multi-department
12.1.3.Multi-site
12.2.  Modality Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.CT
12.2.2.MRI
12.2.3.X-ray
12.2.4.Ultrasound
12.2.5.Mammo
12.2.6.PET
12.3.  Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Cardiology
12.3.2.Oncology
12.3.3.Neurology
12.3.4.Others
12.4.  End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Hospital
12.4.2.ASC
12.4.3.Diagnostic centre
12.5.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13.Middle East and Africa (MEA) Vendor Neutral Archive (VNA) & PACS Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
13.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Department
13.1.2.Multi-department
13.1.3.Multi-site
13.2.  Modality Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.CT
13.2.2.MRI
13.2.3.X-ray
13.2.4.Ultrasound
13.2.5.Mammo
13.2.6.PET
13.3.  Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Cardiology
13.3.2.Oncology
13.3.3.Neurology
13.3.4.Others
13.4.  End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Hospital
13.4.2.ASC
13.4.3.Diagnostic centre
13.5.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14.Latin America Vendor Neutral Archive (VNA) & PACS Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
14.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Department
14.1.2.Multi-department
14.1.3.Multi-site
14.2.  Modality Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.CT
14.2.2.MRI
14.2.3.X-ray
14.2.4.Ultrasound
14.2.5.Mammo
14.2.6.PET
14.3.  Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Cardiology
14.3.2.Oncology
14.3.3.Neurology
14.3.4.Others
14.4.  End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Hospital
14.4.2.ASC
14.4.3.Diagnostic centre
14.5.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.GE HealthCare
15.2.2.Fujifilm Holdings Corporation
15.2.3.Sectra AB
15.2.4.Philips Healthcare
15.2.5.Siemens Healthineers
15.2.6.Agfa-Gevaert Group
15.2.7.Canon Medical Systems Corporation
15.2.8.Novarad Corporation
15.2.9.IBM Watson Health
15.2.10.Carestream Health
16. Research Methodology 
17. Appendix and Abbreviations 

Key Market Players

  • GE HealthCare
  • Fujifilm Holdings Corporation
  • Sectra AB
  • Philips Healthcare
  • Siemens Healthineers
  • Agfa-Gevaert Group
  • Canon Medical Systems Corporation
  • Novarad Corporation
  • IBM Watson Health
  • Carestream Health

Related Industry Reports